By analyzing tumor immune-related pathways, we found that the pathways including “expanded immune,” “APC costimulation,” and “T cell costimulation” were significantly active in the high-PR-Score group; and the immune molecules including HLA, checkpoint, and CD8 T cell effector were also more active in the high-PR-Score group (Figure 7(i)). Here, CD8A is linked to neoplasm.